Electromed vs EDAP TMS
Electromed reported revenue of $74 million in fiscal 2026, about the same as EDAP TMS's $70 million in fiscal 2025. Electromed's revenue grew 15.3% in its latest year, and EDAP TMS's grew 1.6%. Electromed had an operating margin of 18.8%, against -35.0% at EDAP TMS. Their fiscal years end in different months (June 30 and December 31), so the periods don't line up exactly.
Side by side
| Electromed | EDAP TMS | |
|---|---|---|
| Latest fiscal year | FY2026, Jun 30, 2026 | FY2025, Dec 31, 2025 |
| Revenue | $74M | $70M |
| Revenue growth | 15.3% | 1.6% |
| Revenue growth a year, last 5 years | 15.6% | — |
| Gross margin | 78.5% | 42.5% |
| Operating margin | 18.8% | −35.0% |
| Net margin | 15.3% | −41.5% |
| Free cash flow | $8M | — |
| Free cash flow margin | 11.4% | — |
| Return on capital | — | −83.4% |
| Net debt to EBITDA | — | — |
| Dividends and buybacks | $4M | $0M |
| Change in diluted share count | −2.5% | 0.4% |
| Last close | $23.26 | $2.82 |
| P/E at the last close | 16.9× | — |
| Insider trades, last 12 months | sold $2.2 million | bought $450,700, sold $0 |
| Piotroski F-score | — | — |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
ElectromedEDAP TMS
Operating margin
Percent of revenue
ElectromedEDAP TMS
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
ElectromedEDAP TMS
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Electromed and EDAP TMS pages.